BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $354,349 | $21,644 | $27,644 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $2,754 | $3,662 | $386 |
| Total Curr. Assets | $357,103 | $25,306 | $28,030 |
| Property Plant & Equip (Net) | $791 | $518 | $374 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $100 | $100 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $240 | $0 | $25 |
| Total NC Assets | $1,131 | $618 | $399 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $358,234 | $25,924 | $28,429 |
| Liabilities | – | – | – |
| Payables | $1,996 | $1,866 | $2,261 |
| Short-Term Debt | $6,202 | $45,051 | $216 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $7,826 | $3,313 | $0 |
| Other Curr. Liab. | $11,751 | $7,938 | $3,384 |
| Total Curr. Liab. | $27,775 | $58,168 | $5,861 |
| LT Debt | $2,502 | $8,201 | $2,252 |
| Deferred Rev, NC | $4,674 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $156 | $132,951 | $132,875 |
| Total NC Liab. | $7,332 | $141,152 | $135,127 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $202 | $194 | $49 |
| Total Liabilities | $35,107 | $199,320 | $140,988 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$252,811 | -$181,702 | -$117,848 |
| AOCI | $245 | $164 | $167 |
| Other Equity | $575,693 | $8,142 | $5,122 |
| Total Equity | $323,127 | -$173,396 | -$112,559 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $358,234 | $25,924 | $28,429 |
| Net Debt | -$345,645 | $31,608 | -$25,176 |